Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
Eur J Prev Cardiol ; 19(5): 1005-33, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22637741

RESUMEN

In a previous paper, as the first of a series of three on the importance of characteristics and modalities of physical activity (PA) and exercise in the management of cardiovascular health within the general population, we concluded that, in the population at large, PA and aerobic exercise capacity clearly are inversely associated with increased cardiovascular disease risk and all-cause and cardiovascular mortality and that a dose­response curve on cardiovascular outcome has been demonstrated in most studies. More and more evidence is accumulated that engaging in regular PA and exercise interventions are essential components for reducing the severity of cardiovascular risk factors, such as obesity and abdominal fat, high BP, metabolic risk factors, and systemic inflammation. However, it is less clear whether and which type of PA and exercise intervention (aerobic exercise, dynamic resistive exercise, or both) or characteristic of exercise (frequency, intensity, time or duration, and volume) would yield more benefit for each separate risk factor. The present paper, therefore, will review and make recommendations for PA and exercise training in the management of cardiovascular health in individuals with cardiovascular risk factors. The guidance offered in this series of papers is aimed at medical doctors, health practitioners, kinesiologists, physiotherapists and exercise physiologists, politicians, public health policy makers, and individual members of the public. Based on previous and the current literature overviews, recommendations from the European Association on Cardiovascular Prevention and Rehabilitation are formulated regarding type, volume, and intensity of PA and regarding appropriate risk evaluation during exercise in individuals with cardiovascular risk factors.


Asunto(s)
Actividades Cotidianas , Enfermedades Cardiovasculares/prevención & control , Terapia por Ejercicio/normas , Ejercicio Físico/fisiología , Obesidad/rehabilitación , Guías de Práctica Clínica como Asunto , Salud Pública , Enfermedades Cardiovasculares/etiología , Humanos , Obesidad/complicaciones , Factores de Riesgo
2.
Acta Chir Belg ; 110(3): 339-41, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20690519

RESUMEN

Everolimus is a recently developed immunosuppressive drug for patients following solid organ transplantation. Its mechanism of action, independent of calcineurin, is different from that of ciclosporin and tacrolimus and because of its lack of nephrotoxicity, it is a good alternative for calcineurin inhibitors in patients with renal dysfunction. In this paper we describe the case report of a 66-year-old caucasian female who underwent heart transplantation in December 2006. After induction with rabbit anti-thymocytic globulin, her immunosuppressive therapy comprised the combination of tacrolimus, mycophenolate mofetil (MMF) and steroids. Because of renal dysfunction, tacrolimus was changed for everolimus after 6 months. Unfortunately our patient developed severe stomatitis with aphthous ulcerations, shortly after the switch. Despite oral therapy (local anaesthetics), severe pain and malnourishment prompted interruption of everolimus and MMF and therapy was changed to ciclosporin and azathioprine. In addition, thalidomide was added. During the following weeks, there was progressive healing of the ulcerations. MMF was re-introduced and thalidomide was stopped after 6 weeks, without recurrent lesions after 4 months of follow-up.


Asunto(s)
Fisura Anal/inducido químicamente , Trasplante de Corazón , Inmunosupresores/efectos adversos , Úlceras Bucales/inducido químicamente , Sirolimus/análogos & derivados , Estomatitis/inducido químicamente , Anciano , Antiinflamatorios no Esteroideos/uso terapéutico , Azatioprina/uso terapéutico , Ciclosporina/uso terapéutico , Quimioterapia Combinada , Everolimus , Femenino , Humanos , Inmunosupresores/administración & dosificación , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapéutico , Sirolimus/administración & dosificación , Sirolimus/efectos adversos , Tacrolimus/uso terapéutico , Talidomida/uso terapéutico
4.
Acta Chir Belg ; 104(3): 290-6, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15285539

RESUMEN

The gap between the number of potential recipients of a cardiac graft and the availability of donor hearts is still growing. A proper selection of heart transplant candidates is mandatory to ensure that patients in critical need, who are likely to benefit from this procedure, are identified. The work-up of a patient with terminal chronic heart failure includes a comprehensive cardiac and systemic evaluation. Critical in the decision is the exclusion of irreversible pulmonary hypertension. Furthermore, underlying diseases that could compromise short- and long-term prognosis after transplantation should be carefully assessed. The mortality on the waiting list and the growing pool of patients with chronic heart failure that is excluded from transplantation has stimulated the search for alternative treatment modalities. Besides a pharmacologic approach, the last few years have witnessed a tremendous evolution in so-called mechanical devices, designed to improve both morbidity and mortality of these patients. Although several of these devices have only just entered the clinical phase, internal cardioverter defibrillators, left ventricular assist devices and biventricular pacemakers can no longer be viewed as experimental tools.


Asunto(s)
Insuficiencia Cardíaca/cirugía , Trasplante de Corazón , Selección de Paciente , Enfermedad Crónica , Trasplante de Corazón/normas , Humanos , Índice de Severidad de la Enfermedad
5.
Eur Heart J ; 23(23): 1854-60, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12445534

RESUMEN

AIMS: Physical reconditioning of patients with chronic heart failure (CHF) improves exercise capacity and restores endothelial function and skeletal muscle changes. The effects of 4 months combined endurance/resistance exercise training on cytokines and cytokine receptors in patients with CHF were studied. In addition, changes in submaximal and maximal exercise performance were addressed. METHODS AND RESULTS: Twenty-three patients with stable CHF due to coronary artery disease (CAD, n=12) or idiopathic dilated cardiomyopathy (IDCM, n=11) were trained for 4 months. Blood sampling for measurement of plasma concentrations (ELISA) of interleukin (IL)-6, tumour necrosis factor (TNF)-alpha, soluble TNF receptor 1 (sTNFR1) and 2 (sTNFR2), as well as cardiopulmonary exercise testing were performed at baseline and after 4 months. Training induced a significant decrease in sTNFR1 (P=0.02) for the total population, and in both sTNFR1 (P=0.01) and sTNFR2 (P=0.02) concentrations for the CAD group only. IL-6 and TNF-alpha levels were not altered. Cytokine concentrations remained unchanged in an untrained age- and sex-matched control group. NYHA functional class, submaximal and maximal workrate were significantly improved in both patient groups. Oxygen uptake at the anaerobic threshold (P=0.002) and at peak exercise increased in the CAD patients only (P=0.008). CONCLUSION: Besides an overall beneficial effect on exercise capacity, combined endurance/resistance exercise training has an anti-inflammatory effect in patients with CHD and CAD.


Asunto(s)
Enfermedad Coronaria/rehabilitación , Terapia por Ejercicio/métodos , Insuficiencia Cardíaca/rehabilitación , Receptores del Factor de Necrosis Tumoral/sangre , Adulto , Anciano , Anciano de 80 o más Años , Enfermedad Coronaria/sangre , Citocinas/sangre , Tolerancia al Ejercicio , Femenino , Insuficiencia Cardíaca/sangre , Humanos , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Consumo de Oxígeno , Resistencia Física
7.
Ann Allergy Asthma Immunol ; 87(3): 243-5, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11570623

RESUMEN

BACKGROUND: Intravenous administration of cyclosporine, which contains Cremophor EL (a polyethoxylated castor oil; BASF, Berlin, Germany), has occasionally resulted in an anaphylactic reaction. An apparent hypersensitivity reaction (bronchospasm and decrease in blood pressure) had occurred during heart transplantation in a 59-year-old woman after intravenous infusion of cyclosporine. Subsequent oral administration of cyclosporine precipitated no reaction. OBJECTIVE: The purpose of this study was to attempt to ascertain the mechanism responsible for the anaphylactic reaction. METHODS: Hypersensitivity investigations, including total serum IgE and allergen-specific IgE quantifications, skin testing, and basophil activation tests by flow cytometric determination of CD63 upregulation were undertaken in the study patient and in two healthy control subjects who were free of medication. RESULTS: The results of intradermal testing with Cremophor EL were positive after 15 minutes in the study patient only. Both cyclosporine and Cremophor EL induced considerable activation of the basophils from our study patient, with an upregulation of CD63 expression from 1% to 39% and 55%, respectively. In contrast, the expression of CD63 on basophils from the two control subjects remained essentially unchanged. CONCLUSIONS: The negative investigative findings in the control subjects, the patient's clinical manifestations in temporal relationship to the infusion, her positive results on intradermal testing with Cremophor, the basophil activation test results, and her uneventful course after oral administration of cyclosporine strongly support the presence of IgE antibodies to Cremophor EL in our patient.


Asunto(s)
Anafilaxia , Ciclosporina/efectos adversos , Hipersensibilidad a las Drogas , Ciclosporina/administración & dosificación , Femenino , Trasplante de Corazón , Humanos , Inmunoglobulina E , Infusiones Intravenosas , Persona de Mediana Edad
8.
J Heart Lung Transplant ; 20(8): 904-7, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11502414

RESUMEN

This report describes the diagnostic difficulty encountered in a young female patient presenting with neurologic symptoms, atrial fibrillation and severe left ventricular systolic dysfunction, eventually leading to cardiac transplantation. The scrutiny used in the evaluation of the particular aspect of the left ventricle, and the integration of the information obtained from echocardiography, angiography and magnetic resonance imaging, led to the diagnosis of a rare and mostly unknown cause of cardiac failure. The correct identification of this entity is mandatory because enhanced risk of thromboembolism and malignant arrhythmia should be anticipated. A review of the literature revealed only 6 patients in whom isolated non-compaction of the left ventricle was treated by heart transplantation.


Asunto(s)
Fibrilación Atrial/cirugía , Cardiomiopatías/cirugía , Trasplante de Corazón , Embolia Intracraneal/cirugía , Disfunción Ventricular Izquierda/cirugía , Adulto , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/patología , Cardiomiopatías/diagnóstico , Cardiomiopatías/patología , Diagnóstico Diferencial , Diagnóstico por Imagen , Femenino , Estudios de Seguimiento , Ventrículos Cardíacos/patología , Humanos , Embolia Intracraneal/diagnóstico , Embolia Intracraneal/patología , Disfunción Ventricular Izquierda/diagnóstico , Disfunción Ventricular Izquierda/patología
10.
Transplantation ; 71(10): 1481-3, 2001 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-11391239

RESUMEN

BACKGROUND: Prognosis of solid organ cancer in immunosuppressed hosts is generally dismal. Therefore, every effort to identify patients with asymptomatic carcinomas before transplantation should be encouraged. METHODS: Sixty-seven patients referred for heart transplantation were examined adhering to the scheme proposed at the 24th Bethesda Conference. To increase the sensitivity of this work-up, the following items were added: tumor marker assays (prostate-specific antigen in males, carcino embryogenic antigen), abdominal ultrasound, CT scan of the abdomen and the thorax, mammography/echography of the breasts, PAP smear, colonoscopy if carcino embryogenic antigen abnormal or occult blood in stool, prostate echography if prostate-specific antigen abnormal or prostate hypertrophy. RESULTS: Carcinoma was detected in 10 of the 67 patients; for 8 patients of this cancer group, transplantation was denied. Importantly, 9 of the 10 malignancies were detected by means of the diagnostic items that were added to the standard screening protocol. There were no significant differences between the cancer and the non-cancer group regarding mean age, sex, etiology of heart failure, and smoking history. Stratifying patients in younger (i.e., < or =54 years) and older (i.e., > or =55 years) age groups showed a significantly greater proportion of older patients in the cancer group (8/10=80%) compared to the non-cancer group (25/57=44%), P=0.04. After a mean follow-up of 34 months, 5 of the 36 transplanted patients developed a malignancy (4 skin carcinomas, 1 non-Hodgkin lymphoma). There have been no malignancy-related deaths until now. CONCLUSION: The importance of a thorough screening program in the triage of candidates with preexisting malignancies, especially in an older patient population, is illustrated in this report.


Asunto(s)
Trasplante de Corazón , Tamizaje Masivo , Neoplasias/diagnóstico , Adulto , Anciano , Carcinoma/epidemiología , Carcinoma/etiología , Femenino , Humanos , Incidencia , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/etiología , Masculino , Persona de Mediana Edad , Neoplasias/epidemiología , Neoplasias/etiología , Países Bajos , Complicaciones Posoperatorias , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/etiología
12.
Acta Cardiol ; 56(1): 39-40, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11315123

RESUMEN

We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic cibenzoline intoxication. Treatment consisted of catecholamines and repetitive infusions of Ringer lactate. Cardiac function and symptoms recovered completely.


Asunto(s)
Antiarrítmicos/envenenamiento , Bloqueo de Rama/inducido químicamente , Gasto Cardíaco Bajo/inducido químicamente , Imidazoles/envenenamiento , Trastornos de la Visión/inducido químicamente , Anciano , Bloqueo de Rama/tratamiento farmacológico , Gasto Cardíaco Bajo/tratamiento farmacológico , Cardiotónicos/uso terapéutico , Dobutamina/uso terapéutico , Femenino , Humanos , Soluciones Isotónicas/uso terapéutico , Lactato de Ringer , Trastornos de la Visión/tratamiento farmacológico
14.
Acta Chir Belg ; 101(5): 226-31, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11758106

RESUMEN

OBJECTIVE: The Abiomed BVS 5000 ventricular assist device (VAD) has been approved in Belgium for emergency cardiac support in patients with postcardiotomy failure with the aim of native heart function recovery. Other indications have emerged from world wide experience, but the indication and usefulness of emergency implantation of assist devices is often debated. METHODS: To decide which patients benefit most from emergency ventricular assist device implantation, we retrospectively reviewed our results of mechanical circulatory support with Abiomed in 20 patients over a 4-year period. Fifteen patients with mean age 58 +/- 6 years experienced postcardiotomy failure and underwent biventricular assist device (BVAD) implantation (group A), after elective (n = 9) or after emergency coronary artery bypass grafting (CABG) (n = 6). Five patients (group B), with mean age 35 +/- 19 years, had an implantation for other underlying conditions: hypertrophic cardiomyopathy (n = 3), myocarditis (n = 1) and primary cardiac allograft failure (n = 1). RESULTS: Of these two groups, eight and two patients respectively needed cardiopulmonary resuscitation before VAD implantation. The mean duration of support in both groups was 5.8 (range 12 h-13 days) and 4.4 days (range 2 h-9 days) respectively. Six and two patients could be weaned from the device and nine and one patients respectively, died on the device. Two patients in group B underwent successful heart transplantation and four patients in group A died after weaning. Two patients in the postcardiotomy group and four patients in group B survived (13% and 80%) with an overall survival and discharge rate of 30%. CONCLUSION: Although sample sizes are small, better survival rates with emergency Abiomed BVS 5000 implantation were obtained in the non postcardiotomy group (group B). For patients in the postcardiotomy group, outcome was negatively influenced by cardiac arrest and resuscitation before urgent CABG. Since death is the only alternative for these patients in cardiogenic shock and organ recovery cannot be predicted, we continue to consider emergency VAD implantation in this patient population.


Asunto(s)
Tratamiento de Urgencia , Corazón Auxiliar , Choque Cardiogénico/etiología , Choque Cardiogénico/terapia , Disfunción Ventricular/complicaciones , Disfunción Ventricular/terapia , Adolescente , Adulto , Anciano , Puente de Arteria Coronaria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Choque Cardiogénico/mortalidad , Tasa de Supervivencia , Factores de Tiempo , Resultado del Tratamiento , Disfunción Ventricular/mortalidad
16.
N Engl J Med ; 343(4): 299; author reply 299-300, 2000 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-10928877
17.
Chest ; 116(5): 1473-5, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10559117

RESUMEN

This case report describes the devastating consequences of spontaneous coronary dissection in a 36-year-old female patient. Surgical revascularization was attempted, but diffuse myocardial infarction developed. The patient was bridged to heart transplantation but died secondary to multiple organ failure. To our knowledge, this is the only reported case of spontaneous dissection of the three main coronary arteries due to severe cystic medial necrosis.


Asunto(s)
Enfermedades del Tejido Conjuntivo/complicaciones , Vasos Coronarios/patología , Infarto del Miocardio/etiología , Adulto , Enfermedades del Tejido Conjuntivo/patología , Angiografía Coronaria , Diagnóstico Diferencial , Resultado Fatal , Femenino , Humanos , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/patología , Necrosis , Rotura Espontánea
18.
Heart ; 82(4): 465-70, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10490562

RESUMEN

OBJECTIVE: To determine whether coil stents are as effective as tubular stents in improving coronary flow velocity reserve (CFVR) after stent deployment. METHODS: Distal CFVR was measured with a 0. 014 inch Doppler guide wire before and after stenting in 33 patients. A coil stent was implanted in 16 patients and a tubular stent was used in 17 patients. Coronary flow velocity within the stent was also recorded during a slow pullback. RESULTS: Following placement of the stents, the percentage diameter stenosis was similar for both the tubular and coil stents (mean (SE) 11 (2)% v 13 (2)%, NS). However, distal CFVR was higher after stenting with a tubular stent compared with a coil stent (2.46 (0.13) v 1.96 (0.14), p < 0.05). Furthermore, pullback through the stent detected a major flow velocity increase within coil stents but not in tubular stents (83 (24)% v 5 (5)%, p < 0.05). CONCLUSIONS: In spite of similar angiographic improvement, placement of coil stents was associated with inferior functional results compared with tubular stents. The flow velocity acceleration within the coil stents suggests the presence of a residual narrowing within the stent, which is not appreciated on angiography.


Asunto(s)
Angioplastia Coronaria con Balón , Circulación Coronaria , Enfermedad Coronaria/terapia , Stents , Análisis de Varianza , Velocidad del Flujo Sanguíneo , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Ecocardiografía Doppler , Humanos , Persona de Mediana Edad , Resultado del Tratamiento
20.
Acta Cardiol ; 53(1): 23-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9638966

RESUMEN

Hypertrophic cardiomyopathy is an important cause of sudden death in young and asymptomatic patients. Young athletes and patients with unexplained sudden death, including their relatives, should be screened for its presence. Risk stratification identifies a high-risk group, in which preventive measures should be taken to reduce the risk for sudden death: moderate to heavy physical activity has to be avoided and arrhythmias with haemodynamic impact should be rigorously prevented.


Asunto(s)
Cardiomiopatía Hipertrófica/complicaciones , Muerte Súbita Cardíaca/etiología , Adolescente , Cardiomiopatía Hipertrófica/cirugía , Muerte Súbita Cardíaca/prevención & control , Trasplante de Corazón , Humanos , Masculino , Esfuerzo Físico , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...